Keywords:
Immune checkpoint therapy; T cell receptor (TCR) sequencing; T cells; immune repertoire; machine learning; tumour-infiltrating lymphocytes
Abstract:
Immune checkpoint therapy (ICT) causes durable tumour responses in a subgroup of patients, but it is not well known how T cell receptor beta (TCRβ) repertoire dynamics contribute to the therapeutic response.